| Catalog# | Promotion  |
Size | Price | Availability |
| CM003-0.1A1CoV | 100 μg | $360.00 |
| Description | Human anti-SARS-CoV-2 Spike Antibody [CR3022] recognizes human SARS-CoV and CoV-2 Spike protein with high affinity. The binding site is amino acids 318-510 (RBD, Receptor Binding Domain) in the S1 subunit of the spike protein. Coronavirus spike protein conducts the process that interacts with cellular receptor and membrane fusion to allow virus entering into target cells. Spike protein also can be used to define the specificity of the virus and be used as a critical target for vaccine design. The glycosylated spike protein can be detected in the virus-infected cell and cell culture medium. The RBD is responsible for recognizing the cell surface receptor. |
| Form | Liquid |
| Reactivity | SARS-CoV & CoV-2 Spike protein |
| Clonality | Monoclonal, clone LGSV201 |
| Immunogen | SARS-CoV-2 VLP |
| Concentration | 1 mg/mL |
| Conjugation | Unconjugated |
| Storage Buffer | Phosphate Buffered Saline containing 0.03% ProClin 300, pH 7.4. |
| Isotype | IgG1 |
Recommended dilution factor:
ELISA: 1:5000-20000
WB:1:1000-5000
IFA: 1:500-1000
FACS: Assay dependent
Note: Working dilution for specific application should be determined by the investigator to obtain the best conditions.
| Stability & Storage | The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage. |
| Shipping | This product is stable after storage at: 2-8°C for 2 weeks under sterile conditions from date of receipt. -20°C or -80°C for 12 months under sterile conditions from date of receipt. Avoid repeated freeze/thaw cycles. Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C. |
No experimental data is available
No references are available
Follow Us
